Forschungsprojekte
Ergebnisse pro Seite:
10
2022 - 2025
Type-I Interferons – a double-edged sword in myeloproliferative neoplasms and chronic viral infections (SFB 1292, TP21)- Prof. Dr. Markus Radsak,
- Dr. Sabine Muth
2022 - 2026
Exploring KrasG12V-specific TCR-like CAR redirected T cells for immunotherapy in non-small cell lung cancer (NSCLC)- PD Dr. Udo Hartwig
2022 - 2026
Targeting chromatin complexes to reverse AML immune escape for engineered cell therapy (SFB 1292/2, TP 12)- Dr. Michael Kühn,
- Prof. Dr. Evelyn Ullrich
2022 - 2040
oNKord, NK-Zellen bei AML in Remission mit Resterkrankung ohne SZT (#1394)- Dr. Eva Wagner-Drouet